Therapy Areas and Research

Why Our Research Matters

Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. Bringing together the best of biology and technology, Amgen reaches millions of patients with its medicines, helping make people’s lives easier, fuller and longer.

• Amgen is a pioneer in cardiovascular research, with a legacy of addressing unmanaged LDL cholesterol (LDL-C), one of the most modifiable risk factors for heart attack and stroke.
• We are working to drive innovations in care for obesity, one of the world's most common and often misunderstood diseases, with a profound unmet medical need.
• As a core and growing part of Amgen’s mission to serve patients, we are working on new treatments for some of the more than 10,000 different rare diseases that impact around 400 million people globally.
• Amgen’s early-stage research seeks newer, faster and more personalized ways to help patients living with inflammatory disease.
• We deliver innovative treatments and support for fighting some of the world’s hardest-to-treat cancers, propelling the next generation of targeted small molecules, innovative immunotherapies to help a patient’s immune system target cancer cells and new ways to target specific cancer biomarkers.

Our research is rooted in the belief that for every patient there is a solution. We work tirelessly to identify potential new therapies and improve existing treatments. Fueled by our scientific curiosity and out-of-the-box thinking, we're committed to bringing new medicines to patients faster than ever before. We're also reimagining how clinical studies are conducted, using new technologies and approaches to protocol design to make them more efficient and more representative of the patients who will take our medicines.